COMMUNIQUÉS West-GlobeNewswire
-
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved
15/07/2026 -
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
15/07/2026 -
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026
15/07/2026 -
Lark Health Partners with Samsung to Bring AI-Powered Health Coach to U.S. Seniors
15/07/2026 -
SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET
15/07/2026 -
TobaGrown Acquires Manitoba Cannabis Extract Brands HWY 59 and Banter
15/07/2026 -
New Research Reveals Patient Frustrations With AI: When Patients Call, They Want To Reach a Person
15/07/2026 -
Inteleos Names First Chief Product Officer to Lead New Healthcare Innovation Division
15/07/2026 -
Omada Health to Host its First Investor Day on September 10, 2026
15/07/2026 -
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
15/07/2026 -
VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million
15/07/2026 -
Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing
15/07/2026 -
Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
15/07/2026 -
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
15/07/2026 -
UroGen Receives New U.S. Patent Allowance Expected to Provide Protection into July 2044 for ZUSDURI™ and UGN-103
15/07/2026 -
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
15/07/2026 -
Cannara annonce un chiffre d’affaires record au troisième trimestre et une rentabilité soutenue, parallèlement à l’extension de sa distribution nationale et à l’accélération de l’augmentation de ses capacités
15/07/2026 -
Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion
15/07/2026 -
aTyr Pharma to Present Subgroup Analysis of Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis at WASOG 2026
15/07/2026
Pages